Arimidex [anastrozole] study (non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)

Trial Profile

Arimidex [anastrozole] study (non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Feb 2013

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 13 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top